Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA

[1]  F. Montorsi,et al.  Comparing long‐term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy , 2016, BJU international.

[2]  Phil Quirke,et al.  Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profiling , 2015, BMC Medical Genomics.

[3]  Robert Petryszak,et al.  ArrayExpress update—simplifying data submissions , 2014, Nucleic Acids Res..

[4]  T. Brüning,et al.  Chromosomal alterations in exfoliated urothelial cells from bladder cancer cases and healthy men: a prospective screening study , 2014, BMC Cancer.

[5]  H. Mostafid,et al.  Does the nonurologic scientific community understand urothelial bladder cancer? , 2014, European urology.

[6]  G. Kristiansen,et al.  Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies , 2014, Critical reviews in clinical laboratory sciences.

[7]  J. Witjes,et al.  EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. , 2014, European urology.

[8]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of urothelial bladder carcinoma , 2014, Nature.

[9]  Adam Kiezun,et al.  Whole-exome sequencing and clinical interpretation of FFPE tumor samples to guide precision cancer medicine , 2013, Nature Medicine.

[10]  Dennis C. Friedrich,et al.  Whole-exome sequencing and clinical interpretation of formalin-fixed , paraffin-embedded tumor samples to guide precision cancer medicine , 2014 .

[11]  M. Knowles,et al.  Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity , 2014, Nature Reviews Cancer.

[12]  The Cancer Genome Atlas Research Network,et al.  Comprehensive molecular characterization of urothelial bladder carcinoma , 2014, Nature.

[13]  G. Cancel-Tassin,et al.  Detection of specific chromosomal aberrations in urine using BCA-1 (oligo-CGH-array) enhances diagnostic sensitivity and predicts the aggressiveness of non-muscle-invasive bladder transitional cell carcinoma , 2013, World Journal of Urology.

[14]  K. Pantel,et al.  Real-time liquid biopsy in cancer patients: fact or fiction? , 2013, Cancer research.

[15]  Chris Sander,et al.  Emerging landscape of oncogenic signatures across human cancers , 2013, Nature Genetics.

[16]  D. Kwiatkowski,et al.  Identification of Nine Genomic Regions of Amplification in Urothelial Carcinoma, Correlation with Stage, and Potential Prognostic and Therapeutic Value , 2013, PloS one.

[17]  Heng Li.  Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.

[18]  C. Taylor,et al.  Novel Tumor Subgroups of Urothelial Carcinoma of the Bladder Defined by Integrated Genomic Analysis , 2012, Clinical Cancer Research.

[19]  Christopher A. Miller,et al.  VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.

[20]  Marcel Martin.  Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .

[21]  G. Cancel-Tassin,et al.  Diagnostic, staging, and grading of urothelial carcinomas from urine: performance of BCA-1, a mini-array comparative genomic hybridisation-based test. , 2011, European urology.

[22]  M. Zeegers,et al.  The West Midlands Bladder Cancer Prognosis Programme: rationale and design , 2010, BJU international.

[23]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[24]  B. Têtu,et al.  Diagnosis of urothelial carcinoma from urine , 2009, Modern Pathology.

[25]  L. Kiemeney,et al.  The present and future burden of urinary bladder cancer in the world , 2009, World Journal of Urology.

[26]  K. Halling,et al.  Bladder Cancer Detection Using FISH (UroVysion Assay) , 2008, Advances in anatomic pathology.

[27]  P. Chang,et al.  Urinary Cell-Free DNA as a Potential Tumor Marker for Bladder Cancer , 2007 .

[28]  P. Chang,et al.  Urinary cell-free DNA as a potential tumor marker for bladder cancer. , 2007, The International journal of biological markers.

[29]  I. Kovalszky,et al.  Deletion analysis of tumor and urinary DNA to detect bladder cancer: urine supernatant versus urine sediment. , 2007, Oncology reports.

[30]  L. Kiemeney,et al.  Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy. , 2004, European urology.

[31]  Ronald W. Davis,et al.  Multiplexed genotyping with sequence-tagged molecular inversion probes , 2003, Nature Biotechnology.

[32]  V. Vasioukhin,et al.  The Origin and Mechanism of Circulating DNA , 2000, Annals of the New York Academy of Sciences.